Selman Keles/iStock via Getty Images Sight Sciences (NASDAQ:SGHT) said Thursday that there will be no change in Medicare coverage for surgeries performed with its OMNI Surgical System in January. The announcement comes after five Medicare Administrative Contractors withdrew final local coverage determinations ((LCDs)) unfavorable to the procedure.

Selman Keles/iStock通过Getty Images Sight Sciences（纳斯达克：SGHT）周四表示，1月份使用其OMNI手术系统进行的手术的医疗保险覆盖率不会发生变化。此前，五家医疗保险管理承包商撤回了对该程序不利的最终当地保险范围决定（LCD）。

The LCDs, related to the micro-invasive surgical procedures (MIGS) for glaucoma, were scheduled to take effect on January 29. Previously, the MACs, WPS Government Health Administrators, Palmetto GBA, Celerian Group Company, National Government Services, and Noridian Healthcare Solutions had identified OMNI as investigational for use in specific MIGS procedures for adults.

与青光眼微创外科手术（MIG）相关的液晶显示器计划于1月29日生效。此前，MACs、WPS政府卫生管理人员、Palmetto GBA、Celerian Group Company、National Government Services和Noridian Healthcare Solutions已将OMNI确定为用于成年人特定MIGS程序的研究性药物。

All five MACs have now confirmed the LCDs will not go into effect as scheduled, and “there will be no change in January 2024 to the current Medicare coverage for MIGS procedures performed with the OMNI Surgical System,” the company said. Wells Fargo analyst Larry Biegelsen, who had predicted the outcome early this week, said that if implemented, the decision would have benefited Glaukos (NYSE:GKOS), allowing broader coverage for its stent-based MIGS procedure called iStent infinite.

该公司表示，所有五家Mac公司现已确认，液晶显示器将不会按计划生效，“2024年1月，使用OMNI手术系统进行的MIGS手术的现行医疗保险范围不会发生变化。”。富国银行（Wells Fargo）分析师拉里·比格尔森（Larry Biegelsen）本周早些时候预测了结果，他表示，如果实施，这一决定将使Glaukos（纽约证券交易所：GKOS）受益，从而使其基于支架的MIGS程序iStent infinite得到更广泛的覆盖。

More on Sight Sciences Sight Sciences, Inc. (SGHT) Q3 2023 Earnings Call Transcript Sight Sciences climbs after update on Medicare coverage for glaucoma procedure Sight Sciences spikes after insider purchases Seeking Alpha’s Quant Rating on Sight Sciences Historical earnings data for Sight Sciences .

更多关于Sight Sciences Sight Sciences，Inc.（SGHT）2023年第三季度收益通话记录Sight Sciences在更新Medicare青光眼手术覆盖率后攀升Sight Sciences内幕购买寻求Alpha对Sight Sciences历史收益数据的量化评级后飙升。